HOME >> BIOLOGY >> NEWS
'Sewer gas' induces suspended animation without decreasing blood pressure

VIRGINIA BEACH, VA (October 9, 2006) -- Hydrogen sulfide gas can induce a state of suspended animation in mice while maintaining normal blood pressure, a finding that researchers hope will one day help treat critically-ill patients.

Hydrogen sulfide gas, sometimes called sewer gas, produces a noxious odor often described as a rotten egg smell. The gas occurs naturally in swamps, springs and volcanoes. While usually harmless, it can be toxic if breathed in sufficient quantity, explained Gian Paolo Volpato, one of the study's authors.

The study, entitled "Cardiovascular response to breathing hydrogen sulfide in a murine model: separating the effects of body temperature," will be presented Sunday, Oct. 8, at The American Physiological Society conference, "Comparative Physiology 2006: Integrating Diversity," in Virginia Beach, VA, Oct. 8-11. Gian Paolo Volpato, Robert J. Searles, Marielle Scherrer-Crosbie, Oleg V. Evgenov, Kenneth D. Block, Fumito Ichinose and Warren M. Zapol of the Massachusetts General Hospital in Boston carried out the study.

The research built on a 2005 study from the University of Washington in Seattle and the Fred Hutchinson Cancer Research Center, which found that when mice breathed the gas, they went into a hibernation-like state. Their metabolic rate dropped by 90% and their body temperature decreased to nearly the temperature of the surrounding air.

New research looks at cardiovascular effects

"We wanted to confirm the Seattle study and record the effects the gas has on blood pressure, heart rate, respiratory rate and the activity level of the mice," Volpato explained. They administered 80 parts per million of hydrogen sulfide gas to their mice and found their:

  • heart rate fell from 500 beats per minute to 200 beats per minute
  • respiration rate decreased from 120 breaths to 25 breaths per minute
  • core body temperature fell from 38 C to 30 C
  • activi
    '"/>


Contact: Christine Guilfoy
cguilfoy@the-aps.org
301-634-7253
American Physiological Society
9-Oct-2006


Page: 1 2 3

Related biology news :

1. Antibody retards growth and induces death in liver cancer cells
2. AVN944 inhibits IMPDH and induces apoptosis-related biomarkers in patients with hematologic cancers
3. Reconstructed 1918 influenza virus induces immune response that fails to protect
4. High blood pressure induces low fat metabolism in heart muscle
5. New combination treatment induces regression of prostate cancer
6. Human trial proves ricin vaccine safe, induces neutralizing antibodies; further tests planned
7. Mouse model reveals that oncoprotein induces abnormal preleukemic blood cell progenitors
8. Past experience of pheromones induces dominant courtship behavior in fruit flies
9. Coming soon -- Protein synthesis without amino acids?
10. Research without borders: Head of Santa Fe Institute to address NSF
11. 2-protein team would be lost without each other

Post Your Comments:
(Date:5/11/2015)... 11, 2015 Curemark LLC, a privately held ... a new Phase III double blind, randomized, placebo-controlled clinical ... CM-AT, on all children ages 3-8 with Autism. Previously, ... III double blinded clinical trial for CM-AT in children ... the digestive enzyme chymotrypsin. This new trial will help ...
(Date:5/8/2015)... Synaptics Inc. (NASDAQ: SYNA ), the leading ... the executive management team will present at the following investor ... Telecom Conference Date: May 18, 2015 Time: 10:40am ... Cowen and Company Technology, Media & ... The New York Palace Hotel, New York, NY ...
(Date:5/6/2015)... 2015 LifeBEAM, a developer of bio-sensing technology, ... today that they will expand their partnership in bio-sensing ... cycling helmet and the first joint project between the ... in order to give cyclists more style choices and ... and Lazer announced their plan to release a new ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2Synaptics to Present at Upcoming Investor Conferences 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
(Date:5/21/2015)... NEW YORK , May 21, 2015  Prima ... biotechnology company that is striving to become a leader ... of cancer, recently announced that the final CVac data ... has shown a clear trend for a clinically meaningful ... ("SOC") in second remission patients. In the ...
(Date:5/21/2015)... W. R. Grace & Co. ... Worms, Germany has received good manufacturing practice (GMP) ... International Pharmaceutical Excipient Council (IPEC) Foundation. ... SYLOID® FP brand of pharmaceutical grade excipient silica ... Curtis Bay, Maryland (USA) and Sorocaba, Brazil locations. ...
(Date:5/21/2015)... DUBLIN , May 20, 2015 Research ... announced the addition of the "2015 Global ... to their offering. The primary goal ... of flow cytometry instruments and reagents. Key information ... drive the selection of flow cytometers, predominantly used ...
(Date:5/20/2015)... , May 20, 2015 ... presented preliminary data demonstrating the ability of the ... fibrosis (IPF) from other interstitial lung diseases (ILDs) ... the classifier,s potential to help thousands of patients ... ambiguity in IPF diagnosis – a frequent challenge ...
Breaking Biology Technology:Correction Continues after Big Move - BrokerBank Securities, Inc. 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2Global Survey on Flow Cytometry Adoption Trends 2015 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5
Cached News: